Omental Transposition Surgery for Mild Alzheimer's Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a prospective, single arm, non-randomized, interventional study to evaluate the safety and effectiveness of Omental transposition (OT) in subjects with early stage AD.

Within-subjects (repeated-measures) design will be utilized to compare follow-up outcomes to baseline.

The following assessments will be performed at baseline, then at 1, 3, 6, 12, and 24 months following surgery:

* Montreal Cognitive Assessment (MoCA)
* Alzheimer's Disease Assessment Scale-Cognition (ADAS-Cog)
* General Practitioner Assessment of Cognition (GPCOG)
* Eight-item Informant Interview to Differentiate Aging and Dementia (AD8) Subjects who have early stage AD confirmed by a neuropsychological test (MoCA) and who are healthy enough to undergo surgery.

The experimental procedure to be performed is omental transposition (OT) surgery. It will be performed as a laparoscopic or open procedure for omental lengthening and an open procedure for brain access, with a general surgeon performing the omental lengthening/tunneling and a neurosurgeon performing brain access/brain biopsy/omental placement on brain.

Up to twenty-five (25) subjects, with the first 5 subjects being part of a learning curve group and the next 20 subjects being part of the experimental group.

The duration of each subject's participation will be approximately 25 months from screening through the 24 month follow-up visit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transrectal NOTES Appendectomy - Feasibility Study

NCT01189916

Appendectomy, Laparoscopic Endoscopy

COMPLETED NA

Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy.

NCT05923086

Ileus Postoperative

RECRUITING PHASE2

Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i.e.: Are There Differences in Postoperative Outcome / Convalescence)

NCT02295982

Renal Cancer

COMPLETED NA

Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic Assistance

NCT00962650

Abdominal Adhesions

COMPLETED NA

Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis

NCT04287647

Gastroparesis

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The experimental procedure to be performed is omental transposition surgery, during which a general surgeon and a neurosurgeon work as a team to transpose a pedicle omental graft to the surface of the brain. The general surgeon is responsible for performing a laparotomy/laparoscopy, elongating the omentum into a long pedicle and developing an extensive subcutaneous tunnel up the chest and neck to the head. The neurosurgeon is responsible for performing the craniotomy and securing the omentum on the brain.

Creating an intact omental pedicled flap requires the services of a general surgeon and neurosurgeon. The first step in the operation is to obtain access to the abdominal cavity laparoscopically using four 5cm trocars, or via laparotomy through an upper midline incision. The omentum is then removed from the transverse colon, after which it is separated from its proximal and central attachments to the stomach. The omentum detachments are made directly on the greater curvature of the stomach, leaving the gastroepiploic arteries and veins within the still-connected omentum apron.

Final separation of the omentum from the proximal portion of the stomach is done by dividing the left gastroepiploic vessels, which at the highest proximal level on the stomach become the short gastric vessels. The vascular connections to and from the omentum are now maintained solely from the right gastric and right gastroepiploic vessels. In order for the omental pedicle graft to reach the brain without tension, further surgical tailoring of the omentum is carried out, with care being taken to ensure the preservation of a major omental artery and vein.

After the omentum has been lengthened to an appropriate extent to reach the head, several small (3- to 4-inch) transverse incisions are made on the chest wall slightly lateral to the midline, with the side of the midline to make the transverse incisions depending on which cerebral hemisphere the omentum is to be placed. These transverse incisions are connected subcutaneously, thus creating a tunnel that begins at the upper pole of the midline abdominal incision and travels subcutaneously, up the chest wall and neck to behind the ear.

Although the subcutaneous tissue behind the ear is extremely dense, it is essential that the tunnel at this location be at least 2-3 finger lengths in width so that there is no constriction on the omentum in this particular area within the tunnel. As the omentum in the tunnel passes behind the ear, it goes beneath the base of the scalp flap that had been previously dissected in making the initial craniotomy incision.

The neurosurgery portion of the operation involves removal of a single piece of bone over the temporal-frontal area, opening the dura mater, followed by the removal of patches of arachnoid membrane, with care being taken to avoid blood vessels on the surface of the brain.

At this point in the operation, the omentum is laid directly upon the parietal-temporal-frontal area, after which the dura mater is sutured to the omentum. It is not necessary that the edges of the omentum be applied to the cut edges of the dura since the omentum can be tucked under the edges of the dura for greater coverage of the brain. The edges of the dura are then sewn to the top surface of the omentum using absorbable sutures and the craniotomy is closed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional cohort

Omental transposition for mild Alzheimers Disease

Group Type EXPERIMENTAL

Omental transposition for mild Alzheimers disease

Intervention Type PROCEDURE

An omental pedicle is brought from the abdomen underneath the skin and sewn to the dura matter of the brain via a craniotomy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Omental transposition for mild Alzheimers disease

An omental pedicle is brought from the abdomen underneath the skin and sewn to the dura matter of the brain via a craniotomy.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female subjects between 60 to 85 years of age
2. Montreal Cognitive Assessment (MoCA) score of 11 to 18 (mild AD)
3. Healthy enough to undergo the surgical procedure based on surgical risk factor definitions (ASA ≤ 3, using the ASA classification)
4. Must be able to read and understand English in order to complete all AD assessments
5. All medical illnesses other than dementia must be well controlled
6. Must have legally authorized caregiver if incapable of making their own decisions who is willing and able to perform the following:

1. provide informed consent if the subject is unable to do so;
2. monitor the subject;
3. answer informant based questionnaires;
4. provide transportation and accompany the subject to all visits
7. Subject or caregiver is willing and able to provide written informed consent and assent (if applicable)
8. Subject and/or caregiver are willing to comply with the study procedures and complete the entire study as specified in the protocol

Exclusion Criteria

1. Life expectancy \< 2 years
2. Subject who had or has cancer and is undergoing cancer therapy
3. Previous course of abdominal, cranial or neck radiotherapy or chemotherapy
4. Patients with neck calcifications may be excluded
5. Subject with uncontrolled heart disease, renal disease, or liver disease
6. Subject with diabetes mellitus whose glycoslated Hb (A1C) \> 7
7. Complete blood count (CBC) with white blood cell \<4,000 or platelets \>125,000
8. Subject with uncontrollable hypertension (HTN)
9. Subject with previous abdominal surgery or disorder that could negatively influence the outcome of the OT surgery
10. Subject who has had a craniotomy in the past
11. Recent major surgery within the past 6 months
12. Use of cholinesterase inhibitors within the last 30 days and inability to not take cholinesterase inhibitors throughout the length of the study (about 25 mos)
13. Subject uses non-prescribed drugs of abuse or has a history of drug or alcohol abuse/dependence
14. Use of anticoagulants other then anti-platelet medications
15. Subject has significant central nervous system (CNS) disorder other than Alzheimer's disease
16. Subject has clinical evidence or history of stroke, transient ischemic attack, significant head injury or other unexplained or recurrent loss of consciousness ≥15 minutes
17. Major depressive disorder, schizophrenia, other psychotic disorders, or bipolar disorder
18. Subject has epilepsy
19. Patients with severe extra pyramidal signs
20. Patients with plastic surgery of the neck or face
21. Subject resides in hospital or moderate to high dependency continuous care facility
22. Non-English speaking subjects and/or caregivers
23. Subject has any condition that, in the opinion of the Investigator would preclude the use of the study procedure, may interfere with the evaluation of the procedure-related outcomes, or preclude the subject from completing the follow-up requirements

Minimum Eligible Age

65 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No